continue to site
"Trust in the Lord with all thine heart; and lean not unto thine own understanding. In all thy ways acknowledge him, and he shall direct thy paths."
- Proverbs 3:5-6
October 2022
Issue
health living travel food shop events jobs
home health living travel food shop events jobs trending magazine Contact Us Advertise
Arizona Oncology Welcomes Dr. Basel Shoua
By Christina Caldwell - Monday Aug 15, 2022
Arizona Oncology, a premier provider of advanced cancer care across Arizona, is proud to welcome Basel Shoua, MD, to its medical oncology and hematology team. He joins a compassionate team providing expert care in the Tucson area.

Dr. Shoua earned his medical degree at the University of Aleppo, Faculty of Medicine. He completed his residency in internal medicine at the University of California Los Angeles, Kern Medical Center, where he also served as chief resident. Dr. Shoua completed his fellowship in hematology and oncology at the University of Arizona in Tucson and served as chief hematology and oncology fellow. In 2022, he received the Arizona Clinical Oncology Society Outstanding Fellow Award.

Dr. Shoua will see patients at Arizona Oncology’s Tucson-Rudasill location to provide compassionate, patient-centered care. This location offers outpatient chemotherapy, clinical trials and research, genetic risk assessment, a clinical laboratory, and diet and nutrition services.

“Dr. Shoua’s education and experience make him a wonderful fit for our talented team of physicians at Arizona Oncology,” said Rachel Swart, MD, PhD. “His patient-centric approach to treatment aligns strongly with our mission to provide personalized cancer care.”

Dr. Shoua specializes in bone marrow biopsy and intrathecal chemotherapy. He has a special interest in lung, GI, and breast malignancy, as well as benign and malignant hematology. He is an active member of the American Society of Clinical Oncology, the American Society of Hematology, and the American College of Physicians. He is fluent in English and Arabic.

“I work with my patients and their families to design a treatment plan that’s tailored to their unique needs,” said Dr. Shoua. “My goal is to help my patients live longer while maintaining and improving their quality of life.”

The Tucson-Rudasill office is located at 2070 W. Rudasill Rd., #130, Tucson, AZ, 85704. To learn more or to schedule an appointment, visit arizonaoncology.com.

About Arizona Oncology
Arizona Oncology is one of the largest medical groups in Arizona, with more than 50 physicians devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. Since its inception in 1998, Arizona Oncology has led with the philosophy that it’s beneficial to provide cancer therapies in a community setting, close to patients' homes and support systems. Arizona Oncology specializes in Medical, Gynecologic, and Radiation Oncology, Hematology, Breast Surgery, Colorectal Surgery, Urology, Research, Genetic Risk Assessment, and patient ancillary programs. The physicians and their staff treat patients in many communities throughout the state including Glendale, Goodyear, Green Valley, Phoenix, Prescott, Prescott Valley, Scottsdale, and Tucson. For more information, visit arizonaoncology.com.

Arizona Oncology is a practice in The US Oncology Network (The Network). This collaboration unites the practice with more than 1,200 independent physicians dedicated to delivering value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network is supported by McKesson Corporation, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. Arizona Oncology also participates in clinical trials through US Oncology Research, which has played a role in more than 85 FDA-approved cancer therapies, approximately one-third of all cancer therapies approved by the FDA to
date.

Visit http://www.arizonaoncology.com for more information.